Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 383

1.

Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantation.

Kamoshita S, Murata M, Koyama D, Julamanee J, Okuno S, Takagi E, Miyao K, Goto T, Ozawa Y, Miyamura K, Terakura S, Nishida T, Kiyoi H.

Int J Hematol. 2019 Sep 26. doi: 10.1007/s12185-019-02739-2. [Epub ahead of print]

PMID:
31559562
2.

Analysis of glutathione S-transferase and cytochrome P450 gene polymorphism in recipients of dose-adjusted busulfan-cyclophosphamide conditioning.

Terakura S, Onizuka M, Fukumoto M, Kuwatsuka Y, Kohno A, Ozawa Y, Miyamura K, Inagaki Y, Sawa M, Atsuta Y, Suzuki R, Naoe T, Morishita Y, Murata M; Nagoya Blood and Marrow Transplantation Group.

Int J Hematol. 2019 Sep 25. doi: 10.1007/s12185-019-02741-8. [Epub ahead of print]

PMID:
31555969
3.

Prospective Phase 2 Study of Umbilical Cord Blood Transplantation in Adult Acute Leukemia and Myelodysplastic Syndrome.

Terakura S, Nishida T, Sawa M, Kato T, Miyao K, Ozawa Y, Kohno A, Onishi Y, Fukuhara N, Kasai M, Fujii N, Yokoyama H, Iida H, Kanemura N, Fujieda A, Ago H, Tsutsumi Y, Nakamura F, Yago K, Moriuchi Y, Ota S, Ohashi H, Yanagisawa A, Suzuki R, Kuwatsuka Y, Atsuta Y, Miyamura K, Murata M; Nagoya Blood and Marrow Transplantation Group.

Biol Blood Marrow Transplant. 2019 Sep 20. pii: S1083-8791(19)30632-9. doi: 10.1016/j.bbmt.2019.09.021. [Epub ahead of print]

PMID:
31546004
4.

Prediction of clinical outcome by controlling nutritional status (CONUT) before allogeneic hematopoietic stem cell transplantation in myeloid malignancies.

Araie H, Kawaguchi Y, Okabe M, Lee Y, Ohbiki M, Osaki M, Goto M, Goto T, Morishita T, Ozawa Y, Miyamura K.

Int J Hematol. 2019 Aug 12. doi: 10.1007/s12185-019-02723-w. [Epub ahead of print]

PMID:
31407255
5.

Analysis of violence against older adults in police reports.

Rodrigues RAP, Silva LM, Seredynskyj FL, Fhon JRS, Bolina AF, Miyamura K, Kobayasi DY.

Arch Psychiatr Nurs. 2019 Aug;33(4):407-413. doi: 10.1016/j.apnu.2019.05.004. Epub 2019 May 21.

PMID:
31280787
6.

Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy.

Yamazaki H, Ohta K, Iida H, Imada K, Obara N, Tokumine Y, Tomiyama Y, Usuki K, Imajo K, Miyamura K, Sasaki O, Fanghong Z, Hattori T, Tajima T, Matsuda A, Nakao S.

Int J Hematol. 2019 Aug;110(2):187-196. doi: 10.1007/s12185-019-02683-1. Epub 2019 Jun 10.

PMID:
31183813
7.

Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.

Kurosawa S, Yamaguchi T, Oshima K, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Inamoto Y, Kanda Y, Okamoto S, Atsuta Y.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1851-1858. doi: 10.1016/j.bbmt.2019.05.016. Epub 2019 May 24.

PMID:
31129353
8.

A consideration for efficient unrelated hematopoietic stem cell source acquisition-from an experience of Japan.

Nishiwaki S, Miyamura K, Kanda Y, Takanashi M, Uchida N, Fukuda T, Ikegame K, Ohashi K, Eto T, Ozawa Y, Shiratori S, Iwato K, Matsuoka KI, Hidaka M, Ichinohe T, Atsuta Y, Kodera Y, Okamoto S.

Bone Marrow Transplant. 2019 May 14. doi: 10.1038/s41409-019-0542-0. [Epub ahead of print] No abstract available.

PMID:
31089273
9.

Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT.

Fuji S, Miyamura K, Kanda Y, Fukuda T, Kobayashi T, Ozawa Y, Iwato K, Uchida N, Eto T, Ashida T, Mori T, Sawa M, Ichinohe T, Atsuta Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Int J Hematol. 2019 Jun;109(6):684-693. doi: 10.1007/s12185-019-02631-z. Epub 2019 Mar 15.

PMID:
30877606
10.

High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation.

Miyamura K, Yamashita T, Atsuta Y, Ichinohe T, Kato K, Uchida N, Fukuda T, Ohashi K, Ogawa H, Eto T, Inoue M, Takahashi S, Mori T, Kanamori H, Yabe H, Hama A, Okamoto S, Inamoto Y.

Blood Adv. 2019 Feb 12;3(3):397-405. doi: 10.1182/bloodadvances.2018026039.

11.

Randomized study of imatinib for chronic myeloid leukemia: comparing standard dose escalation with aggressive escalation.

Miyamura K, Ohnishi K, Ohtake S, Usui N, Nakaseko C, Fujita H, Fujisawa S, Sakura T, Okumura H, Iriyama N, Emi N, Fujimaki K, Honda S, Miyazaki Y, Naoe T.

Blood Adv. 2019 Feb 12;3(3):312-319. doi: 10.1182/bloodadvances.2018025981.

12.

Recipient ADAMTS13 Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic Malignancy.

Nomoto H, Takami A, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Nakao S, Morishita E.

Int J Mol Sci. 2019 Jan 8;20(1). pii: E214. doi: 10.3390/ijms20010214.

13.

[Introduction and the current status of unrelated peripheral blood stem cells transplantation in Japan].

Miyamura K.

Rinsho Ketsueki. 2018;59(10):2323-2333. doi: 10.11406/rinketsu.59.2323. Review. Japanese.

PMID:
30305542
14.

Origin of cancer-associated fibroblasts and tumor-associated macrophages in humans after sex-mismatched bone marrow transplantation.

Kurashige M, Kohara M, Ohshima K, Tahara S, Hori Y, Nojima S, Wada N, Ikeda JI, Miyamura K, Ito M, Morii E.

Commun Biol. 2018 Sep 3;1:131. doi: 10.1038/s42003-018-0137-0. eCollection 2018.

15.

Higher Peak Tacrolimus Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation Increase the Risk of Endothelial Cell Damage Complications.

Morishita T, Okabe M, Kawaguchi Y, Lee Y, Ohbiki M, Osaki M, Goto M, Araie H, Sato T, Goto T, Ozawa Y, Miyamura K.

Biol Blood Marrow Transplant. 2018 Dec;24(12):2509-2516. doi: 10.1016/j.bbmt.2018.07.029. Epub 2018 Jul 25.

PMID:
30053646
16.

Extracorporeal photopheresis with TC-V in Japanese patients with steroid-resistant chronic graft-versus-host disease.

Okamoto S, Teshima T, Kosugi-Kanaya M, Kahata K, Kawashima N, Kato J, Mori T, Ozawa Y, Miyamura K.

Int J Hematol. 2018 Sep;108(3):298-305. doi: 10.1007/s12185-018-2483-6. Epub 2018 Jun 29.

PMID:
29959747
17.

Impact of hospital length of stay on the risk of readmission and overall survival after allogeneic stem cell transplantation.

Seto A, Atsuta Y, Kawashima N, Ozawa Y, Miyamura K, Kiyoi H.

Int J Hematol. 2018 Sep;108(3):290-297. doi: 10.1007/s12185-018-2477-4. Epub 2018 Jun 19.

PMID:
29923123
18.

Iodine staining and p16 immunohistochemistry as a novel screening for secondary esophageal neoplasm after hematopoietic stem cell transplantation.

Sato T, Seto A, Kagaya Y, Kawashima N, Koyama D, Morishita T, Ozawa Y, Miyamura K, Yamaguchi T, Haruta JI, Ito M.

Bone Marrow Transplant. 2018 Oct;53(10):1359-1363. doi: 10.1038/s41409-018-0197-2. Epub 2018 May 8. No abstract available.

PMID:
29740179
19.

[Japan Marrow Donor Program and its coordinating process: current situations].

Hirakawa T, Kurosawa S, Tajima K, Yamazaki Y, Ikeda N, Kojima H, Tanaka H, Kanamori H, Miyamura K, Kodera Y, Fukuda T, Program JMD.

Rinsho Ketsueki. 2018;59(2):153-160. doi: 10.11406/rinketsu.59.153. Japanese.

PMID:
29515066
20.

Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 BCR-ABL-positive acute myeloid leukaemia: A case report and literature review.

Harada Y, Nishiwaki S, Sugimoto T, Onodera K, Goto T, Sato T, Kamoshita S, Kawashima N, Seto A, Okuno S, Yamamoto S, Iwasaki T, Ozawa Y, Miyamura K, Akatsuka Y, Sugiura I.

Medicine (Baltimore). 2017 Dec;96(50):e9160. doi: 10.1097/MD.0000000000009160. Review.

21.

Efficacy and safety of autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: A study protocol for a multicenter exploratory prospective study (Auto-Ph17 study).

Nishiwaki S, Sugiura I, Miyata Y, Saito S, Sawa M, Nishida T, Miyamura K, Kuwatsuka Y, Kohno A, Yuge M, Kasai M, Iida H, Kurahashi S, Osaki M, Goto T, Terakura S, Murata M, Nishikawa H, Kiyoi H.

Medicine (Baltimore). 2017 Dec;96(52):e9568. doi: 10.1097/MD.0000000000009568.

22.

Outcomes of strategic alternative donor selection or suspending donor search based on Japan Marrow Donor Program coordination status.

Kawashima N, Nishiwaki S, Shimizu N, Kamoshita S, Watakabe K, Yokohata E, Kurahashi S, Ozawa Y, Miyamura K.

Int J Hematol. 2018 May;107(5):551-558. doi: 10.1007/s12185-018-2413-7. Epub 2018 Jan 27.

PMID:
29374827
23.

[Prior harvesting and cryopreservation of peripheral blood stem cells from related donors: current situations in Japan].

Kobayashi T, Ohashi K, Haraguchi K, Okuyama Y, Hino M, Tanaka J, Ueda Y, Nishida T, Atsuta Y, Takanashi M, Iida M, Muroi K, Yabe H, Miyamura K.

Rinsho Ketsueki. 2017;58(11):2205-2212. doi: 10.11406/rinketsu.58.2205. Japanese.

PMID:
29212970
24.

Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 201.

Harada K, Doki N, Hagino T, Miyawaki S, Ohtake S, Kiyoi H, Miyazaki Y, Fujita H, Usui N, Okumura H, Miyamura K, Nakaseko C, Fujieda A, Nagai T, Yamane T, Sakamaki H, Ohnishi K, Naoe T, Ohno R, Ohashi K.

Ann Hematol. 2018 Jan;97(1):73-81. doi: 10.1007/s00277-017-3156-x. Epub 2017 Dec 2.

PMID:
29196987
25.

Prospective observational study on the first 51 cases of peripheral blood stem cell transplantation from unrelated donors in Japan.

Goto T, Tanaka T, Sawa M, Ueda Y, Ago H, Chiba S, Kanamori H, Nishikawa A, Nougawa M, Ohashi K, Okumura H, Tanimoto M, Fukuda T, Kawashima N, Kato T, Okada K, Nagafuji K, Okamoto SI, Atsuta Y, Hino M, Tanaka J, Miyamura K.

Int J Hematol. 2018 Feb;107(2):211-221. doi: 10.1007/s12185-017-2341-y. Epub 2017 Oct 13.

PMID:
29027623
26.

Design of Wall-Destructive but Membrane-Compatible Solvents.

Kuroda K, Satria H, Miyamura K, Tsuge Y, Ninomiya K, Takahashi K.

J Am Chem Soc. 2017 Nov 15;139(45):16052-16055. doi: 10.1021/jacs.7b08914. Epub 2017 Oct 10.

PMID:
28985068
27.

Ruxolitinib is effective and safe in Japanese patients with hydroxyurea-resistant or hydroxyurea-intolerant polycythemia vera with splenomegaly.

Kirito K, Suzuki K, Miyamura K, Takeuchi M, Handa H, Okamoto S, Gadbaw B, Yamauchi K, Amagasaki T, Ito K, Hino M.

Int J Hematol. 2018 Feb;107(2):173-184. doi: 10.1007/s12185-017-2333-y. Epub 2017 Sep 27.

PMID:
28956263
28.

High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotype.

Koyama D, Murata M, Hanajiri R, Okuno S, Kamoshita S, Julamanee J, Takagi E, Hirano D, Miyao K, Sakemura R, Goto T, Hayakawa F, Seto A, Ozawa Y, Miyamura K, Terakura S, Nishida T, Kiyoi H.

PLoS One. 2017 Sep 25;12(9):e0185213. doi: 10.1371/journal.pone.0185213. eCollection 2017.

29.

Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study.

Takahashi N, Tauchi T, Kitamura K, Miyamura K, Saburi Y, Hatta Y, Miyata Y, Kobayashi S, Usuki K, Matsumura I, Minami Y, Usui N, Fukuda T, Takada S, Ishikawa M, Fujimaki K, Gomyo H, Sasaki O, Ohishi K, Miyake T, Imai K, Suzushima H, Mitsui H, Togitani K, Kiguchi T, Atsuta Y, Ohtake S, Ohnishi K, Kobayashi Y, Kiyoi H, Miyazaki Y, Naoe T; Japan Adult Leukemia Study Group.

Int J Hematol. 2018 Feb;107(2):185-193. doi: 10.1007/s12185-017-2334-x. Epub 2017 Sep 19.

PMID:
28929332
30.

Persistent detection of alternatively spliced BCR-ABL variant results in a failure to achieve deep molecular response.

Yuda J, Miyamoto T, Odawara J, Ohkawa Y, Semba Y, Hayashi M, Miyamura K, Tanimoto M, Yamamoto K, Taniwaki M, Akashi K.

Cancer Sci. 2017 Nov;108(11):2204-2212. doi: 10.1111/cas.13353. Epub 2017 Sep 21.

31.

Surface Structures Formed by a Copper(II) Complex of Alkyl-Derivatized Indigo.

Honda A, Noda K, Tamaki Y, Miyamura K.

Materials (Basel). 2016 Oct 15;9(10). pii: E837. doi: 10.3390/ma9100837.

32.

Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.

Kurosawa S, Oshima K, Yamaguchi T, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Inamoto Y, Kanda Y, Okamoto S, Atsuta Y.

Biol Blood Marrow Transplant. 2017 Oct;23(10):1749-1758. doi: 10.1016/j.bbmt.2017.06.011. Epub 2017 Jun 29.

33.

Responsiveness of the functioning and disability parts of the International Classification of Functioning, Disability, and Health core sets in postacute stroke patients.

Kinoshita S, Abo M, Okamoto T, Kakuda W, Miyamura K, Kimura I.

Int J Rehabil Res. 2017 Sep;40(3):246-253. doi: 10.1097/MRR.0000000000000235.

PMID:
28562474
34.

[A Case Report on a Successful Resection after FOLFIRI plus Cetuximab Therapy for Unresectable Colorectal Cancer with Multiple Liver Metastases].

Kanamori M, Kurumiya Y, Mizuno K, Sekoguchi E, Kobayashi S, Fukami Y, Kiriyama M, Aoyama H, Oiwa T, Miyamura K, Jinno T, Nakashima Y, Mori M.

Gan To Kagaku Ryoho. 2017 May;44(5):417-420. Japanese.

PMID:
28536339
35.

The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation.

Horio T, Mizuno S, Uchino K, Mizutani M, Hanamura I, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Takami A.

Transpl Immunol. 2017 Jun;42:34-39. doi: 10.1016/j.trim.2017.05.003. Epub 2017 May 6.

PMID:
28487238
36.

Toll-like receptor genetic variations in bone marrow transplantation.

Uchino K, Mizuno S, Sato-Otsubo A, Nannya Y, Mizutani M, Horio T, Hanamura I, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Ogawa S, Takami A.

Oncotarget. 2017 Jul 11;8(28):45670-45686. doi: 10.18632/oncotarget.17315.

37.

Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study.

Tojo A, Kyo T, Yamamoto K, Nakamae H, Takahashi N, Kobayashi Y, Tauchi T, Okamoto S, Miyamura K, Hatake K, Iwasaki H, Matsumura I, Usui N, Naoe T, Tugnait M, Narasimhan NI, Lustgarten S, Farin H, Haluska F, Ohyashiki K.

Int J Hematol. 2017 Sep;106(3):385-397. doi: 10.1007/s12185-017-2238-9. Epub 2017 Apr 25.

PMID:
28444644
38.

Long-term treatment with bosutinib in a phase 1/2 study in Japanese chronic myeloid leukemia patients resistant/intolerant to prior tyrosine kinase inhibitor treatment.

Takahashi N, Nakaseko C, Kobayashi Y, Miyamura K, Ono C, Koide Y, Fujii Y, Ohnishi K.

Int J Hematol. 2017 Sep;106(3):398-410. doi: 10.1007/s12185-017-2239-8. Epub 2017 Apr 13.

PMID:
28409328
39.

Increase of bone marrow macrophages and CD8+ T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation.

Kawashima N, Terakura S, Nishiwaki S, Koyama D, Ozawa Y, Ito M, Miyamura K.

Bone Marrow Transplant. 2017 Aug;52(8):1164-1170. doi: 10.1038/bmt.2017.58. Epub 2017 Apr 3.

PMID:
28368374
40.

Retrospective survey and evaluation of first-line antibiotics for chemotherapy-induced febrile neutropenia in patients with acute myeloid leukemia.

Mukoyama N, Nakashima M, Miyamura K, Yoshimi A, Noda Y, Mori K.

Nagoya J Med Sci. 2017 Feb;79(1):17-26. doi: 10.18999/nagjms.79.1.17.

41.

Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Shigematsu A, Kako S, Mitsuhashi K, Iwato K, Uchida N, Kanda Y, Fukuda T, Sawa M, Senoo Y, Ogawa H, Miyamura K, Takada S, Nagamura-Inoue T, Morishima Y, Ichinohe T, Atsuta Y, Mizuta S, Tanaka J.

Int J Hematol. 2017 Jun;105(6):805-811. doi: 10.1007/s12185-017-2197-1. Epub 2017 Feb 14.

PMID:
28197965
42.

Impact of T-cell chimerism on relapse after cord blood transplantation for hematological malignancies: Nagoya Blood and Marrow Transplantation Group study.

Yokohata E, Kuwatsuka Y, Ohashi H, Terakura S, Kawashima N, Seto A, Kurahashi S, Ozawa Y, Goto T, Imahashi N, Nishida T, Miyao K, Sakemura R, Kato T, Sawa M, Kohno A, Sao H, Iida H, Kiyoi H, Naoe T, Miyamura K, Murata M.

Bone Marrow Transplant. 2017 Apr;52(4):612-614. doi: 10.1038/bmt.2016.323. Epub 2017 Jan 9. No abstract available.

PMID:
28067879
43.

Impact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation.

Nakasone H, Fuji S, Yakushijin K, Onizuka M, Shinohara A, Ohashi K, Miyamura K, Uchida N, Takanashi M, Ichinohe T, Atsuta Y, Fukuda T, Ogata M; Complication Working Group of Japanese Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2017 Feb;92(2):171-178. doi: 10.1002/ajh.24613.

44.

Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy.

Miyamura K, Miyamoto T, Tanimoto M, Yamamoto K, Kimura S, Kawaguchi T, Matsumura I, Hata T, Tsurumi H, Saito S, Hino M, Tadokoro S, Meguro K, Hyodo H, Yamamoto M, Kubo K, Tsukada J, Kondo M, Aoki M, Okada H, Yanada M, Ohyashiki K, Taniwaki M.

Leuk Res. 2016 Dec;51:11-18. doi: 10.1016/j.leukres.2016.09.009. Epub 2016 Sep 5.

PMID:
27771544
45.

Comparison of Donor Sources in Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Nationwide Retrospective Study.

Sakaguchi H, Watanabe N, Matsumoto K, Yabe H, Kato S, Ogawa A, Inagaki J, Goto H, Koh K, Yoshida N, Kato K, Cho Y, Kosaka Y, Takahashi Y, Inoue M, Kato K, Atsuta Y, Miyamura K; Donor/Source Working Group of Japan Society of Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2016 Dec;22(12):2226-2234. doi: 10.1016/j.bbmt.2016.09.020. Epub 2016 Sep 22.

46.

Validation of the "Activity and participation" component of ICF Core Sets for stroke patients in Japanese rehabilitation wards

Kinoshita S, Abo M, Miyamura K, Okamoto T, Kakuda W, Kimura I, Urabe H.

J Rehabil Med. 2016 Oct 12;48(9):764-768. doi: 10.2340/16501977-2126.

47.

Autoimmune-like hepatitis after allogeneic hematopoietic stem cell transplantation: humoral hepatic GvHD.

Koyama D, Ito M, Yokohata E, Watakabe K, Onodera K, Goto T, Seto A, Watanabe K, Doisaki M, Ozawa Y, Yamaguchi T, Miyamura K.

Bone Marrow Transplant. 2017 Jan;52(1):151-153. doi: 10.1038/bmt.2016.202. Epub 2016 Aug 15. No abstract available.

PMID:
27526287
48.

A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia.

Kuwatsuka Y, Kanda J, Yamazaki H, Mori T, Miyamura K, Kako S, Uchida N, Ohashi K, Ozawa Y, Takahashi Y, Kato C, Iwato K, Ishiyama K, Kobayashi H, Eto T, Kahata K, Kato J, Miyamoto T, Kato K, Mori S, Atsuta Y, Kimura F, Kanda Y; Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2016 Oct;22(10):1836-1843. doi: 10.1016/j.bbmt.2016.07.002. Epub 2016 Jul 8.

49.

Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignancies.

Uchino K, Mizuno S, Mizutani M, Horio T, Hanamura I, Espinoza JL, Matsuo K, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori TM, Takami A; Japan Marrow Donor Program.

Transpl Immunol. 2016 Sep;38:60-6. doi: 10.1016/j.trim.2016.06.002. Epub 2016 Jun 28.

PMID:
27369862
50.

Occurrence of Karenia papilionacea (Dinophyceae) and its novel sister phylotype in Japanese coastal waters.

Yamaguchi H, Hirano T, Yoshimatsu T, Tanimoto Y, Matsumoto T, Suzuki S, Hayashi Y, Urabe A, Miyamura K, Sakamoto S, Yamaguchi M, Tomaru Y.

Harmful Algae. 2016 Jul;57(Pt A):59-68. doi: 10.1016/j.hal.2016.04.007. Epub 2016 Jun 23.

PMID:
30170722

Supplemental Content

Loading ...
Support Center